Sign up USA
Proactive Investors - Run By Investors For Investors

Small-Cap Snapshot: ADMA Biologics shares rise after FDA accepts its drug application amendment

The biotech acquired the drug Bivigam in an acquisition but production stopped while the facility was renovated
Scientist in a lab
Bivigam is a treatment for immune system disorders

Supervalu Inc (NYSE:SVU) is a top gainer following a US$2.9bn buyout deal from United Natural Foods Inc (NASDAQ:UNFI). The grocery retailer is the primary supplier of Amazon.com Inc’s Whole Foods. Shareholders will receive US$32.50 per share in cash. Shares of the Minnesota-based company were up nearly 65% to US$32.02 in Thursday morning trading.

ADMA Biologics Inc (NASDAQ:ADMA) shares are up following the announcement that the US Food and Drug Administration accepted its amendment to its drug application. The biotech acquired the drug Bivigam, a treatment for immune disorders, in an acquisition. Production stopped while the facility was shut down and renovated. Shares of the New Jersey-based company were up more than 18% to US$5.86.

Genprex Inc (NASDAQ:GNPX) inked a deal with the University of Texas MD Anderson Cancer Center. The pair will work together on a study of its drug Oncoprex, administering it alongside immunotherapies. The clinical-stage gene therapy company will pay the university center US$2mln to conduct the study. Shares of the company were down around 1.5% to US$6.99.

READ: Small-Cap Snapshot: Medical device company Nevro is on the rise after a court rules in its favor

MoSys Inc (NASDAQ:MOSY) was a top decliner after announcing it would soon lose a major customer. The semiconductor company reported earnings of US$0.06 per share compared with an earnings loss of US$0.42 in its previous second quarter. However, news that an unnamed customer would be phasing out its products in the next 24 months offset the positive results. Shares fell more than 40% to US$1.21.

LSB Industries Inc (NYSE:LXU) shares sank as downtime at the chemical maker’s factories weighed on its second-quarter results. The company reported a net loss of US$27.5mln compared with a loss of US$7mln in its previous second quarter. Its El Dorado ammonia facility in Arkansas was out of service after a power outage caused tube failures. Shares of the Oklahoma-based company were down more than 15% to US$6.53.

The Russell 2000 small-cap index was up slightly in Thursday afternoon trading.

View full MOSY profile View Profile

MoSys Timeline

Related Articles

Hong Kong harbour
September 17 2018
The transition of the business through the diversification of legacy assets and investing in new opportunities in Asia is well underway, said chairman John Croft
chrome pipes
June 20 2018
Another change recently was for Tharisa to take over the running of the mine, which involved it buying the fleet from its contractor
picture of oilfield
March 14 2018
Svetlana Mendesh, Chief Financial Officer, said 2016 results were in line with its projections and local market trends.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use